Related references
Note: Only part of the references are listed.Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men
Maeve Kiely et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker et al.
CIRCULATION RESEARCH (2021)
The rise and fall of aspirin in the primary prevention of cardiovascular disease
Inbar Raber et al.
LANCET (2019)
Oxidant stress as a major determinant of platelet activation in invasive breast cancer
Patrizia Ferroni et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease
Anupama Vasudevan et al.
CORONARY ARTERY DISEASE (2017)
Urinary 11-Dehydro-Thromboxane B2 and Mortality in Patients With Stable Coronary Artery Disease
Peter A. McCullough et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
The lack of aspirin resistance in patients with coronary artery disease
Nora Homorodi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Oxidative stress reflected by increased F2-isoprostanes is associated with increasing urinary 11-dehydro thromboxane B2 levels in patients with coronary artery disease
Peter A. McCullough et al.
THROMBOSIS RESEARCH (2016)
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation
Pastori Daniele et al.
ONCOTARGET (2016)
A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation
Jeff Patrick et al.
POSTGRADUATE MEDICINE (2015)
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action
P. Patrignani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Syed S. Mahmood et al.
LANCET (2014)
Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study
Joao D. Fontes et al.
ATHEROSCLEROSIS (2013)
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk
M. T. Olson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus
Paul R. J. Ames et al.
THROMBOSIS RESEARCH (2012)
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis
Prasanna Ekambaram et al.
CANCER AND METASTASIS REVIEWS (2011)
Effects of Aspirin Responsiveness and Platelet Reactivity on Early Vein Graft Thrombosis After Coronary Artery Bypass Graft Surgery
Tyler J. Gluckman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Urinary thromboxane B2 and thromboxane receptors in bladder cancer: Opportunity for detection and monitoring
Omar Moussa et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
The Thromboxane/Endoperoxide Receptor (TP): The Common Villain
Michel Feletou et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment
F. Santilli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Inhibition of Thromboxane A(2)-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway
M. J. Wacker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid Determinants and Effect on Cardiovascular Risk
John W. Eikelboom et al.
CIRCULATION (2008)
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology
Norimichi Nakahata
PHARMACOLOGY & THERAPEUTICS (2008)
The third generation cohort of the national heart, lung, and blood institute's Framingham Heart Study: Design, recruitment, and initial examination
Greta Lee Splansky et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population
Nauder Faraday et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway - A 700-patient study of aspirin resistance
Andrew L. Frelinger et al.
CIRCULATION (2006)
Thromboxane A2-induced arrhythmias in the anesthetized rabbit
MJ Wacker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation
US Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Platelet activation in patients with colorectal cancer
MG Sciulli et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
The adhesion molecule P-selectin and cardiovascular disease
AD Blann et al.
EUROPEAN HEART JOURNAL (2003)
The clinical implications of endothelial dysfunction
ME Widlansky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension
ME Widlansky et al.
HYPERTENSION (2003)
Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity
K Kabashima et al.
NATURE IMMUNOLOGY (2003)
Obesity and systemic oxidative stress - Clinical correlates of oxidative stress in the Framingham Study
JF Keaney et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
2,3-Dinor-5,6-dihydro-15-F2t-isoprostane:: a bioactive prostanoid metabolite
X Hou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Augmented vasoconstriction and thromboxane formation by 15-F2t-isoprostane (8-iso-prostaglandin F2α) in immature pig periventricular brain microvessels
X Hou et al.
STROKE (2000)
Share Paper
